Internalization of Tissue Factor-Rich Microvesicles by Platelets Occurs Independently of GPIIb-IIIa, and Involves CD36 Receptor, Serotonin Transporter and Cytoskeletal Assembly

Journal of Cellular Biochemistry

Volumn 117, Issue 2, 2016, Pages 448-457

  Lopez Vilchez, Irene ^a   Diaz Ricart, Maribel ^a   Galan, Ana M ^a   Roque, Merce ^a   Caballo, Carolina ^a   Molina, Patricia ^a   White, James G ^b   Escolar, Gines ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

CELL DERIVED MICROPARTICLES; CYTOSKELETON; INTERNALIZATION; PLATELETS; TISSUE FACTOR

Indexed keywords

CONTRACTILE PROTEIN; FIBRINOGEN RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SCAVENGER RECEPTOR; SCAVENGER RECEPTOR CD36; SEROTONIN TRANSPORTER; THROMBOPLASTIN; UNCLASSIFIED DRUG; BETA3 INTEGRIN; CD36 ANTIGEN; CD36 PROTEIN (93-110); GLYCOPROTEIN RECEPTOR GPIB-IX; PEPTIDE FRAGMENT; RHOA PROTEIN, HUMAN; THROMBIN RECEPTOR;

ACTIN POLYMERIZATION; ARTICLE; CONTROLLED STUDY; CYTOSKELETON; ELECTRON MICROSCOPY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MEMBRANE MICROPARTICLE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; CELL CULTURE; METABOLISM; PHYSIOLOGY; PROTEIN TRANSPORT;

ANTIGENS, CD36; BLOOD PLATELETS; CELL-DERIVED MICROPARTICLES; CELLS, CULTURED; CYTOSKELETON; ENZYME ACTIVATION; HUMANS; INTEGRIN BETA3; PEPTIDE FRAGMENTS; PHOSPHATIDYLINOSITOL 3-KINASES; PLATELET AGGREGATION; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PROTEIN TRANSPORT; RHOA GTP-BINDING PROTEIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SIGNAL TRANSDUCTION; THROMBOPLASTIN;

EID: 84970925800     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.25293     Document Type: Article

References (50)

1. Aras O, Shet A, Bach RR, Hysjulien JL, Slungaard A, Hebbel RP, Escolar G, Jilma B, Key NS,. 2004. Induction of microparticle and cell-associated intravascular tissue factor in human endotoxemia. Blood 103: 4545-4553.
2. Balasubramanian V, Grabowski E, Bini A, Nemerson Y,. 2002. Platelets, circulating tissue factor, and fibrin colocalize in ex vivo thrombi: Real-time fluorescence images of thrombus formation and propagation under defined flow conditions. Blood 100: 2787-2792.
3. Bodie SL, Ford I, Greaves M, Nixon GF,. 2001. Thrombin-induced activation of RhoA in platelet shape change. Biochem Biophys Res Commun 287: 71-76.
4. Bradford MM,. 1976. Rapid and sensitive method for quantitation of microgram quantities of protein utilizing principle of protein-dye binding. Anal Biochem 72: 248-254.
5. Brambilla M, Camera M, Colnago D, Marenzi G, De Metrio M, Giesen PL, Balduini A, Veglia F, Gertow K, Biglioli P, Tremoli E,. 2008. Tissue factor in patients with acute coronary syndromes: Expression in platelets, leukocytes, and platelet-leukocyte aggregates. Arterioscler Thromb Vasc Biol 28: 947-953.
6. Camera M, Brambilla M, Boselli D, Facchinetti L, Canzano P, Rossetti L, Toschi V, Tremoli E,. 2012. Response: Functionally active platelets do express tissue factor. Blood 119: 4339-4341.
7. Cimmino G, D'Amico C, Vaccaro V, D'Anna M, Golino P,. 2011. The missing link between atherosclerosis, inflammation and thrombosis: is it tissue factor ? Expert Rev Cardiovasc Ther 9: 517-523.
8. Clawson CC, White JG,. 1971. Platelet interaction with bacteria. II. Fate of the bacteria. Am J Pathol 65: 381-397.
9. Davi G, Patrono C,. 2007. Platelet activation and atherothrombosis. N Engl J Med 357: 2482-2494.
10. del Conde I, Shrimpton CN, Thiagarajan P, Lopez JA,. 2005. Tissue factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 106: 1604-1611.
11. Diener HC,. 2006. Secondary stroke prevention with antiplatelet drugs: Have we reached the ceiling ? Int J Stroke 1: 4-8.
12. Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter AA,. 1993. CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem 268: 11811-11816.
13. Escolar G, Diaz-Ricart M, Cases A, Castillo R, Ordinas A, White JG,. 1993. Abnormal cytoskeletal assembly in platelets from uremic patients. Am J Pathol 143: 823-831.
14. Escolar G, Diaz-Ricart M, Gomez-Gil E, Serra M, Gasto C, Bozzo J, Galan AM,. 2005. Serotonergic mechanisms: A potential link between affective disorders and cardiovascular risk. Drugs Today (Barc) 41: 721-743.
15. Escolar G, Lopez-Vilchez I, Diaz-ricart M, White JG, Galan AM,. 2008. Internalization of tissue factor by platelets. Thromb Res 122: S37-S41.
16. Estebanell E, Diaz-Ricart M, Escolar G,. 2000. Alterations in cytoskeletal organizatrion and tyrosine phosphorylation in PCs prepared by the BC method. Transfusion 40: 535-542.
17. Galan AM, Lopez-Vilchez I, Diaz-Ricart M, Navalon F, Gomez E, Gasto C, Escolar G,. 2009. Serotonergic mechanisms enhance platelet-mediated thrombogenicity. Thromb Haemost 102: 511-519.
18. Ghosh A, Li W, Febbraio M, Espinola RG, McCrae KR, Cockrell E, Silverstein RL,. 2008. Platelet CD36 mediates interactions with endothelial cell-derived microparticles and contributes to thrombosis in mice. J Clin Invest 118: 1934-1943.
19. Giesen PA, Rauch U, Bohrmann B, Kling D, Roque M, Fallon JT, Badimon JJ, Himber J, Riederer MA, Nemerson Y,. 1999. Blood-borne tissue factor: Another view of thrombosis. Proc Natl Acad Sci USA 96: 2311-2315.
20. Hathcock JJ, Nemerson Y,. 2004. Platelet deposition inhibits tissue factor activity: In vitro clots are impermeable to factor Xa. Blood 104: 123-127.
21. Heger CD, Collins RN,. 2004. Platelet activation and "crossover appeal": Rab and Rho families united by common links to serotonin. Mol Interv 4: 79-81.
22. Hoffman M, Monroe DM,. 2003. The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis. Dm Disease-A-Month 49: 14-21.
23. Jackson SP,. 2011. Arterial thrombosis-insidious, unpredictable and deadly. Nat Med 17: 1423-1436.
24. Jackson SP, Yap CL, Anderson KE,. 2004. Phosphoinositide 3-kinases and the regulation of platelet function. Biochem Soc Trans 32: 387-392.
25. Leslie M,. 2010. Cell biology. Beyond clotting: The powers of platelets. Science 328: 562-564.
26. Lievens D, von Hundelshausen P,. 2011. Platelets in atherosclerosis. Thromb Haemost 106: 827-838.
27. Lopez-Vilchez I, Diaz-Ricart M, White JG, Escolar G, Galan AM,. 2009. Serotonin enhances platelet procoagulant properties and their activation induced during platelet tissue factor uptake. Cardiovasc Res 84: 309-316.
28. Lopez-Vilchez I, Escolar G, Diaz-Ricart M, Fuste B, Galan AM, White JG,. 2007. Tissue factor-enriched vesicles are taken up by platelets and induce platelet aggregation in the presence of factor VIIa. Thromb Haemost 97: 202-211.
29. Lopez-Vilchez I, Galan AM, Hernandez MR, Caballo C, Roque M, Diaz-Ricart M, White JG, Escolar G,. 2012. Platelet-associated tissue factor enhances platelet reactivity and thrombin generation in experimental studies in vitro. Thromb Res 130: e294-e300.
30. Lopez-Vilchez I, Serra-Millas M, Navarro V, Rosa HM, Villalta J, Diaz-Ricart M, Gasto C, Escolar G, Galan AM,. 2014. Prothrombotic platelet phenotype in major depression: Downregulation by antidepressant treatment. J Affect Disord 159: 39-45.
31. Mackman N,. 2004. Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vasc Biol 24: 1015-1022.
32. Mackman N,. 2008. Triggers, targets and treatments for thrombosis. Nature 451: 914-918.
33. Morel O, Toti F, Hugel B, Freyssinet JM,. 2004. Cellular microparticles: A disseminated storage pool of bioactive vascular effectors. Curr Opin Hematol 11: 156-164.
34. Morrell CN, Aggrey AA, Chapman LM, Modjeski KL,. 2014. Emerging roles for platelets as immune and inflammatory cells. Blood 123: 2759-2767.
35. Muller I, Klocke A, Alex M, Kotzsch M, Luther T, Morgenstern E, Zieseniss S, Zahler S, Preissner K, Engelmann B,. 2003. Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets. FASEB J 17: 476-478.
36. Nakatani D, Sato H, Sakata Y, Shiotani I, Kinjo K, Mizuno H, Shimizu M, Ito H, Koretsune Y, Hirayama A, Hori M,. 2005. Influence of serotonin transporter gene polymorphism on depressive symptoms and new cardiac events after acute myocardial infarction. Am Heart J 150: 652-658.
37. Niu H, Chen X, Gruppo RA, Li D, Wang Y, Zhang L, Wang K, Chai W, Sun Y, Ding Z, Gartner TK, Liu J,. 2012. Integrin alphaIIb-mediated PI3K/Akt activation in Platelets. PLoS ONE 7: e47356.
38. Perez-Pujol S, Aras O, Lozano M, Cocking-Johnson D, Key NS, White JG, McCullough J, Escolar G,. 2005. Stored platelets contain residual amounts of tissue factor: Evidence from studies on platelet concentrates stored for prolonged periods. Transfusion 45: 572-579.
39. Polgar J, Matuskova J, Wagner DD,. 2005. The P-selectin, tissue factor, coagulation triad. J Thromb Haemost 3: 1590-1596.
40. Rauch U, Bonderman D, Bohrmann B, Badimon JJ, Himber J, Riederer MA, Nemerson Y,. 2000. Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. Blood 96: 170-175.
41. Sauer WH, Berlin JA, Kimmel SE,. 2003. Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction. Circulation 108: 32-36.
42. Stuart LM, Deng J, Silver JM, Takahashi K, Tseng AA, Hennessy EJ, Ezekowitz RA, Moore KJ,. 2005. Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain. J Cell Biol 170: 477-485.
43. Sturgeon SA, Jones C, Angus JA, Wright CE,. 2008. Advantages of a selective beta-isoform phosphoinositide 3-kinase antagonist, an anti-thrombotic agent devoid of other cardiovascular actions in the rat. Eur J Pharmacol 587: 209-215.
44. Tilley RE, Holscher T, Belani R, Nieva J, Mackman N,. 2008. Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patients. Thromb Res 122: 604-609.
45. Topol EJ, Byzova TV, Plow EF,. 1999. Platelet GPIIb-IIIa blockers. LANCET 353: 227-231.
46. Toschi V, Gallo R, Lettino M, Fallon JT, Gertz D, Fernandezortiz A, Chesebro JH, Badimon L, Nemerson Y, Fuster V,. 1997. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation 95: 594-599.
47. Walther DJ, Peter JU, Winter S, Holtje M, Paulmann N, Grohmann M, Vowinckel J, Alamo-Bethencourt V, Wilhelm CS, Ahnert-Hilger G, Bader M,. 2003. Serotonylation of small GTPases is a signal transduction pathway that triggers platelet [alpha]-granule release. Cell 115: 851-862.
48. White JG,. 2005. Platelets are covercytes, not phagocytes: Uptake of bacteria involves channels of the open canalicular system. Platelets 16: 121-131.
49. Zillmann A, Luther T, Muller I, Kotzsch M, Spannagl M, Kauke T, Oelschlagel U, Zahler S, Engelmann B,. 2001. Platelet-associated tissue factor contributes to the collagen-triggered activation of blood coagulation. Biochem Biophys Res Commun 281: 603-609.
50. Zucker-Franklin D,. 1981. Endocytosis by human platelets: Metabolic and freeze-fracture studies. J Cell Biol 91: 706-715.